WAAREE Energies has announced the grant of 17,062 stock options to eligible employees under its Employee Stock Option Plan 2021 (ESOP 2021). The Nomination and Remuneration Committee approved the grant. Each option’s exercise price is set at ₹10. Vesting occurs gradually over six years, starting with 15% after the first year and culminating in 20% in the fifth and sixth years.

ESOP Grant Details

WAAREE Energies has approved the allocation of 17,062 stock options to its employees through the Waaree Employee Stock Option Plan 2021 (ESOP 2021). This decision was made by the Nomination and Remuneration Committee.

Vesting Schedule

The options vest incrementally over a six-year period as follows:

• Year 1: 15%
• Year 2: 15%
• Year 3: 15%
• Year 4: 15%
• Year 5: 20%
• Year 6: 20%

Key Terms

The exercise price for each option is ₹10. Once vested, options are exercisable within four years from their vesting date.

Source: BSE

Kotak Mahindra Bank has released its key financial figures for the quarter ended September 30, 2025. Net advances reached ₹4,62,552 crores, showing a 15.8% year-over-year increase. Total deposits hit ₹5,28,776 crores, marking a 14.6% rise compared to the previous year. CASA deposits also saw significant growth, reaching ₹2,23,791 crores, indicating a positive financial trajectory for the bank.

Key Financial Highlights

Kotak Mahindra Bank reports significant growth in key financial metrics for the quarter ending September 30, 2025.

Advances Performance

The bank’s net advances for the period reached ₹4,62,552 crores, a 15.8% increase compared to ₹3,99,522 crores in the same period last year (YoY). The average net advances stood at ₹4,47,809 crores, reflecting a 14.6% YoY growth.

Deposit Growth

Total deposits for the period ended at ₹5,28,776 crores, showing a 14.6% increase from ₹4,61,454 crores in the corresponding quarter of the previous year. The average total deposits were ₹5,10,138 crores, up by 14.4% YoY.

CASA Performance

The bank’s CASA (Current Account Savings Account) deposits reached ₹2,23,791 crores, an 11.2% increase compared to ₹2,01,275 crores year-over-year. The average CASA deposits amounted to ₹1,98,250 crores, a 6.2% increase YoY.

Quarterly Comparison

Comparing the quarter’s performance to the previous quarter (Q1: Apr-Jun 2025), net advances increased by 4.0%. Total deposits rose by 3.1%, and CASA deposits increased by 6.7%. These figures highlight sustained growth across key areas for the bank.

Source: BSE

Lupin Limited has provided an update regarding the U.S. FDA inspection of its Pithampur Unit-2 manufacturing facility. The inspection, which took place from July 8 to July 17, 2025, has resulted in an inspection classification of “Official Action Indicated (OAI)”. The company is committed to resolving the compliance issues and maintaining CGMP standards at its manufacturing facilities.

Pithampur Unit-2 Inspection Result

Lupin Limited announced an update regarding the U.S. FDA inspection of its Pithampur Unit-2 manufacturing facility. The inspection concluded on July 17, 2025, following a period from July 8, 2025.

Official Action Indicated (OAI)

The U.S. FDA has classified the inspection as “Official Action Indicated (OAI)”. Lupin is committed to working with the U.S. FDA to satisfactorily resolve any compliance issues.

Commitment to Compliance

Lupin Limited reiterated its commitment to be compliant with CGMP standards across all of its manufacturing facilities. The company is taking steps to address the observations made during the inspection.

Source: BSE

SOBHA has announced a robust performance in Q2 FY26, achieving real estate sales of ₹19.03 Bn, a 61.4% increase compared to Q2 FY25. This growth contributed to a record first half (H1) with sales reaching ₹39.81 Bn. The company saw significant contributions from Bangalore and NCR, with Kerala also showing strong performance. Bangalore alone accounted for 69.7% of the quarterly sales.

Strong Sales Performance

SOBHA reported a strong quarter with real estate sales reaching ₹19.03 Bn in Q2 FY26, marking a significant growth of 61.4% compared to the same period last year (Q2 FY25). The company’s share of these sales amounted to ₹15.37 Bn (80.8%). This translates to a new sales area of 1.39 Mn sft, with an average price realization of ₹13,648 / sft.

Key Regional Contributions

The company’s performance was bolstered by contributions from key regions:

• Bangalore: Contributed 69.7% of quarterly sales, with a value of ₹13,264 mn, driven by improved momentum at SOBHA Town Park.
• NCR: Added ₹3,097 mn, with major sales from SOBHA Aranya and SOBHA Aurum.
• Kerala: Contributed ₹1,848 mn to quarterly sales, sustained by festive demand.

Record First Half Performance

The strong Q2 performance contributed to a record first half of FY26, with total sales reaching ₹39.81 Bn. This represents the best H1 performance for the company, achieved with a new sales area of 2.84 Mn sft.

Sales Area Breakdown

*NCR includes Gurgaon and Greater Noida; Kerala includes Kochi, Thrissur, Calicut and Trivandrum; Tamil Nadu includes Chennai and Coimbatore; Other Regions includes Hyderabad and Pune

Key Operational Highlights

• Achieved highest-ever H1-FY26 sales value of ₹39,814 mn, a growth of 30.4% over H1-FY25.
• Completed 1.18 Mn sft of saleable area, delivering 591 homes across projects including SOBHA Manhattan Towers, SOBHA Sentosa and SOBHA Royal Pavilion in Bangalore during the quarter.
• Launched the extension of SOBHA Lifestyle, a boutique luxury villa project spread across 2.12 Acres in North Bangalore.

Source: BSE

Canara Bank announced that its subsidiary, Canara Robeco Asset Management Company Limited, has filed a Red Herring Prospectus (RHP) with the Registrar of Companies on October 3, 2025. This filing is a key step towards a potential Initial Public Offering (IPO) of the asset management company. The IPO aims to unlock value and provide growth capital for the subsidiary. Further details regarding the IPO, such as issue size and price band, are expected to be announced in due course.

IPO Prospectus Filed

Canara Bank has announced a significant development regarding its subsidiary, Canara Robeco Asset Management Company Limited. As of October 3, 2025, the subsidiary has officially filed its Red Herring Prospectus (RHP) with the Registrar of Companies.

Details of the Filing

The filing of the RHP marks a crucial step in the process of launching an Initial Public Offering (IPO) for Canara Robeco Asset Management Company Limited. This move is intended to potentially unlock value for Canara Bank and its shareholders by allowing the asset management arm to access public markets for capital and growth.

Source: BSE

A shift in registered ownership of 87,09,801 shares of Global Health Limited triggered a regulatory disclosure. The shares, previously held jointly by Mr. Sunil Sachdeva and Mrs. Suman Sachdeva, have been transferred to Mr. Sunil Sachdeva’s individual Demat account. S A S Fininvest LLP remains the beneficial owner. The transfer, executed on September 30, 2025, involved no monetary consideration and complies with SEBI regulations.

Details of Share Transfer

On October 3, 2025, Global Health Limited announced a change in the registered ownership of a significant number of its shares. A total of 87,09,801 shares were transferred from a joint Demat account to an individual account.

Ownership Restructuring

The shares, representing 3.24% of the total share/voting capital, were previously held jointly by Mr. Sunil Sachdeva and Mrs. Suman Sachdeva. The transfer resulted in Mr. Sunil Sachdeva becoming the sole registered holder in his individual Demat account. S A S Fininvest LLP continues to be the beneficial owner of these shares. The effective date of the transfer was September 30, 2025.

Impact on Shareholding Percentage

Before the transfer, the acquirer, along with persons acting in concert, held 2,99,91,884 shares, representing 11.158% of the company. Following the transfer, the total holding remains unchanged at 2,99,91,884 shares, and the percentage holding is still 11.158%. The nature of the transaction was an off-market transfer.

Reason for the Transfer

The transfer reflects an internal restructuring of shareholding within S A S Fininvest LLP, with the aim of streamlining registered ownership. A resolution was passed during a partners’ meeting on May 16, 2025, approving the change from joint to individual ownership for administrative efficiency.

Source: BSE

IDBI Bank has released its unaudited financial results, showcasing key performance indicators for the quarter ended September 30, 2024. The bank reported a total business of ₹4,78,547 Crore, total deposits of ₹2,77,602 Crore, CASA deposits of ₹1,33,639 Crore, and net advances of ₹2,00,944 Crore. These figures are compared against results from June 30, 2025 and September 30, 2025, with year-over-year variance also provided.

Financial Performance Overview

IDBI Bank’s unaudited financial results provide a snapshot of its performance as of September 30, 2024. These figures offer insights into the bank’s operational scale and financial health. The results are provisional and subject to review.

Key Financial Figures

The bank reported the following key figures:

• Total Business: ₹4,78,547 Crore (Unaudited) as of September 30, 2024, compared to ₹5,08,775 Crore as of June 30, 2025 and ₹5,33,839 Crore as of September 30, 2025. This represents a year-over-year growth of 12%.
• Total Deposits: ₹2,77,602 Crore (Unaudited) as of September 30, 2024, compared to ₹2,96,868 Crore as of June 30, 2025 and ₹3,03,531 Crore as of September 30, 2025. This shows a year-over-year increase of 9%.
• CASA Deposit: ₹1,33,639 Crore (Unaudited) as of September 30, 2024, compared to ₹1,32,553 Crore as of June 30, 2025 and ₹1,39,056 Crore as of September 30, 2025. The year-over-year growth stands at 4%.
• Net Advances: ₹2,00,944 Crore (Unaudited) as of September 30, 2024, compared to ₹2,11,907 Crore as of June 30, 2025 and ₹2,30,308 Crore as of September 30, 2025, reflecting a year-over-year increase of 15%.

Source: BSE

India Ratings and Research has affirmed Star Health’s rating at ‘IND AA+’ with a Stable outlook, reaffirming its subordinated debt rating. The affirmation highlights Star Health’s market leadership, robust underwriting, and differentiated operating model, holding a 33% retail health insurance market share. In FY25, it reported a gross written premium of ₹16,781 crore, driven by its distribution network and brand equity.

Rating Reflects Strong Market Position

The ‘IND AA+’ rating with a Stable outlook reflects Star Health’s financial strength, supported by its operational efficiency and solvency ratio of 2.21x as of March 2025. This rating indicates the company’s strong market leadership, prudent risk selection, and efficient claims processing systems.

Financial Highlights

Star Health reported a gross written premium (GWP) of ₹16,781 crore in FY25. The company also reported a net profit increase to ₹646 crore for FY25, driven by a wide distribution network and strong brand equity.

Claims Processing Strength

The company’s efficient claims processing system, supported by a large team of in-house doctors, is a key differentiator. The technology-enabled framework ensures quick, transparent, and fair settlement for policyholders.

Commitment to Healthcare

Star Health is dedicated to expanding access to quality healthcare protection and aligning with the vision of ‘Insurance for All by 2047’. The company continues to drive industry standards in service delivery and financial strength.

Source: BSE

TVS Motor Company has successfully completed the acquisition of 100% of the share capital of Engines Engineering S.p.A from ACT S.r.l. The acquisition was finalized on October 3, 2025, making Engines Engineering S.p.A a wholly-owned subsidiary of TVS Motor (Singapore) Pte Ltd. This strategic move aims to enhance TVS Motor’s technological capabilities and expand its global footprint.

Acquisition Complete

TVS Motor Company has finalized the acquisition of 1,000,000 equity shares, representing 100% ownership of Engines Engineering S.p.A. This acquisition was initially announced on September 25, 2025, and has now been successfully concluded.

Subsidiary Status

Effective October 3, 2025, Engines Engineering S.p.A is now officially a wholly owned subsidiary of TVS Motor (Singapore) Pte Ltd, a subsidiary of TVS Motor Company. This acquisition marks a significant step in TVS Motor’s strategic growth and global expansion plans.

Source: BSE